SynthesisFrontiers in cellular and infection microbiology2025
Opportunities and challenges of proximity labeling for microbe-host cell interactions in tumor microenvironment.
Synthesis in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the tumor immune microenvironment, microbes promote tumor progression and metastasis by invading host cancer cells. Blocking these interactions is expected to provide new strategies for inhibiting tumor progression and metastasis, as well as opening up new avenues for immunotherapy. However, technological means of studying the interaction between microorganisms and host cancer cells are still limited. Proximity labeling, a widely used method for analyzing biomolecular and cellular interactions, has the potential to analyze microbe-host cell interactions quantitatively, uncovering the key factors that influence these interactions within the tumor immune microenvironment in order to control tumor initiation and progression. Furthermore, proximity labeling based strategies can be applied to high-throughput drug screening aimed at disrupting pathogenic microbe-host interactions, contributing to the development of therapeutics against advanced and metastatic tumors. This paper provides a systematic review of the topic, introducing cutting-edge microbiological mechanisms that have attracted the attention of oncologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.